H1 Announces Strategic Partnership with Mirai Advisors

We’re pleased to highlight our strategic partnership with Stephanie Bova and Mirai Advisors. Under Stephanie’s leadership, Mirai Advisors partners with senior healthcare leaders to deploy AI and enterprise technology in ways that produce measurable business outcomes.

In partnership with H1, the Mirai Advisors team will help life science organizations break down organizational silos and harness data and AI to accelerate the development and delivery of life-saving therapies to patients.

Stephanie brings extensive leadership experience across R&D, commercial, manufacturing, and business development at organizations including Novo Nordisk, Becton Dickinson, Novartis, Takeda, and Pfizer. Most recently, Stephanie served as the Corporate Vice President and Digital Transformation Officer for R&D at Novo Nordisk where she led a technology and data portfolio and helped advance the use of AI and process intelligence to improve R&D operations.